Annual Net Income
-$481.19 M
-$7.01 M-1.48%
December 31, 2023
Summary
- As of February 7, 2025, NTLA annual net profit is -$481.19 million, with the most recent change of -$7.01 million (-1.48%) on December 31, 2023.
- During the last 3 years, NTLA annual net income has fallen by -$346.96 million (-258.48%).
- NTLA annual net income is now -3781.52% below its all-time high of -$12.40 million, reached on December 31, 2015.
Performance
NTLA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$135.71 M
+$11.26 M+7.66%
September 30, 2024
Summary
- As of February 7, 2025, NTLA quarterly net profit is -$135.71 million, with the most recent change of +$11.26 million (+7.66%) on September 30, 2024.
- Over the past year, NTLA quarterly net income has dropped by -$13.49 million (-11.04%).
- NTLA quarterly net income is now -12316.47% below its all-time high of -$1.09 million, reached on March 31, 2015.
Performance
NTLA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$522.28 M
-$13.49 M-2.65%
September 30, 2024
Summary
- As of February 7, 2025, NTLA TTM net profit is -$522.28 million, with the most recent change of -$13.49 million (-2.65%) on September 30, 2024.
- Over the past year, NTLA TTM net income has dropped by -$59.85 million (-12.94%).
- NTLA TTM net income is now -47684.45% below its all-time high of -$1.09 million, reached on March 31, 2015.
Performance
NTLA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
NTLA Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.5% | -11.0% | -12.9% |
| 3 y3 years | -258.5% | -89.4% | -128.2% |
| 5 y5 years | -463.8% | -474.2% | -424.7% |
NTLA Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -79.6% | at low | -67.1% | +7.7% | -95.0% | at low |
| 5 y | 5-year | -383.4% | at low | -387.5% | +7.7% | -424.7% | at low |
| alltime | all time | -3781.5% | at low | <-9999.0% | +7.7% | <-9999.0% | at low |
Intellia Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$135.71 M(-7.7%) | -$522.28 M(+2.7%) |
| Jun 2024 | - | -$146.97 M(+36.8%) | -$508.80 M(+4.8%) |
| Mar 2024 | - | -$107.44 M(-18.7%) | -$485.50 M(+0.9%) |
| Dec 2023 | -$481.19 M(+1.5%) | -$132.16 M(+8.1%) | -$481.19 M(+4.1%) |
| Sep 2023 | - | -$122.22 M(-1.2%) | -$462.44 M(+2.0%) |
| Jun 2023 | - | -$123.68 M(+19.9%) | -$453.44 M(+5.3%) |
| Mar 2023 | - | -$103.13 M(-9.1%) | -$430.44 M(-9.2%) |
| Dec 2022 | -$474.19 M(+77.0%) | -$113.41 M(+0.2%) | -$474.19 M(+7.3%) |
| Sep 2022 | - | -$113.23 M(+12.5%) | -$442.02 M(+10.4%) |
| Jun 2022 | - | -$100.68 M(-31.5%) | -$400.43 M(+8.6%) |
| Mar 2022 | - | -$146.87 M(+80.8%) | -$368.56 M(+37.6%) |
| Dec 2021 | -$267.89 M(+99.6%) | -$81.24 M(+13.4%) | -$267.89 M(+17.1%) |
| Sep 2021 | - | -$71.64 M(+4.1%) | -$228.85 M(+23.7%) |
| Jun 2021 | - | -$68.81 M(+48.9%) | -$185.04 M(+24.5%) |
| Mar 2021 | - | -$46.20 M(+9.5%) | -$148.63 M(+10.7%) |
| Dec 2020 | -$134.23 M(+34.9%) | -$42.19 M(+51.6%) | -$134.23 M(+11.6%) |
| Sep 2020 | - | -$27.84 M(-14.1%) | -$120.31 M(+3.6%) |
| Jun 2020 | - | -$32.39 M(+1.8%) | -$116.11 M(+6.1%) |
| Mar 2020 | - | -$31.81 M(+12.5%) | -$109.40 M(+9.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$99.53 M(+16.6%) | -$28.28 M(+19.6%) | -$99.53 M(+10.2%) |
| Sep 2019 | - | -$23.63 M(-8.0%) | -$90.32 M(+1.0%) |
| Jun 2019 | - | -$25.68 M(+17.1%) | -$89.39 M(+4.0%) |
| Mar 2019 | - | -$21.94 M(+15.1%) | -$85.93 M(+0.7%) |
| Dec 2018 | -$85.34 M(+26.4%) | -$19.07 M(-16.0%) | -$85.34 M(-5.4%) |
| Sep 2018 | - | -$22.70 M(+2.2%) | -$90.24 M(+8.9%) |
| Jun 2018 | - | -$22.22 M(+4.0%) | -$82.89 M(+8.7%) |
| Mar 2018 | - | -$21.36 M(-10.9%) | -$76.27 M(+12.9%) |
| Dec 2017 | -$67.54 M(+113.5%) | -$23.96 M(+56.0%) | -$67.54 M(+24.7%) |
| Sep 2017 | - | -$15.36 M(-1.5%) | -$54.14 M(+17.0%) |
| Jun 2017 | - | -$15.59 M(+23.5%) | -$46.27 M(+23.1%) |
| Mar 2017 | - | -$12.63 M(+19.6%) | -$37.58 M(+18.8%) |
| Dec 2016 | -$31.63 M(+155.2%) | -$10.56 M(+41.2%) | -$31.63 M(+20.2%) |
| Sep 2016 | - | -$7.48 M(+8.4%) | -$26.32 M(+20.4%) |
| Jun 2016 | - | -$6.90 M(+3.2%) | -$21.85 M(+21.5%) |
| Mar 2016 | - | -$6.69 M(+27.5%) | -$17.99 M(+45.1%) |
| Dec 2015 | -$12.40 M | -$5.25 M(+73.7%) | -$12.40 M(+73.3%) |
| Sep 2015 | - | -$3.02 M(-0.7%) | -$7.15 M(+73.0%) |
| Jun 2015 | - | -$3.04 M(+178.1%) | -$4.13 M(+278.1%) |
| Mar 2015 | - | -$1.09 M | -$1.09 M |
FAQ
- What is Intellia Therapeutics annual net profit?
- What is the all time high annual net income for Intellia Therapeutics?
- What is Intellia Therapeutics annual net income year-on-year change?
- What is Intellia Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly net income year-on-year change?
- What is Intellia Therapeutics TTM net profit?
- What is the all time high TTM net income for Intellia Therapeutics?
- What is Intellia Therapeutics TTM net income year-on-year change?
What is Intellia Therapeutics annual net profit?
The current annual net income of NTLA is -$481.19 M
What is the all time high annual net income for Intellia Therapeutics?
Intellia Therapeutics all-time high annual net profit is -$12.40 M
What is Intellia Therapeutics annual net income year-on-year change?
Over the past year, NTLA annual net profit has changed by -$7.01 M (-1.48%)
What is Intellia Therapeutics quarterly net profit?
The current quarterly net income of NTLA is -$135.71 M
What is the all time high quarterly net income for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly net profit is -$1.09 M
What is Intellia Therapeutics quarterly net income year-on-year change?
Over the past year, NTLA quarterly net profit has changed by -$13.49 M (-11.04%)
What is Intellia Therapeutics TTM net profit?
The current TTM net income of NTLA is -$522.28 M
What is the all time high TTM net income for Intellia Therapeutics?
Intellia Therapeutics all-time high TTM net profit is -$1.09 M
What is Intellia Therapeutics TTM net income year-on-year change?
Over the past year, NTLA TTM net profit has changed by -$59.85 M (-12.94%)